New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE ...

Hundreds of children and adults with rare forms of cystic fibrosis in England will be able to access “life-changing” new ‘triple-combination’ therapy for the very first time, the NHS has announced.

Most European travellers heading to sub-tropical regions know to make sure they're up to date on their vaccinations. While those mosquito-borne diseases are relatively well known, you may not yet have ...

The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...

HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

Controversial precautionary rules imposed last year for prescribing valproate to potentially fertile males are being assessed ...

July, 11 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating ...

Valneva (NASDAQ:VALN) said on Friday that the European Medicines Agency (EMA) has lifted the suspension on its chikungunya ...

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

Good Manufacturing Practices (GMP) are a system of processes, procedures, and documentation that ensures pharmaceutical ...